This was a randomized , placebo - and positive-controlled , double-dummy , double-blind , four-way crossover study , in which healthy subjects ( n = 85 ) were randomized to 7 days of once-daily treatment of FF/VI ( 200/25 or 800/100g ) or placebo or single-dose oral moxifloxacin ( single-blind , 400mg ) .
